Cytomel (Liothyronine) Overdose and Accidental Excess Dose: Recognition, Treatment, and Prevention

How Liothyronine Works and Why Overdose Matters

Liothyronine sodium is synthetic triiodothyronine (T3), the biologically active thyroid hormone that binds nuclear thyroid receptors and directly increases metabolic rate, oxygen consumption, and thermogenesis. Unlike levothyroxine (T4), which requires peripheral conversion by deiodinase enzymes, T3 acts on target tissues within hours of oral administration 1.

Pharmacokinetic Profile Driving Overdose Risk

T3 is nearly completely absorbed from the GI tract, reaching peak serum concentrations within 2 to 4 hours. Its elimination half-life ranges from 1 to 2 days in euthyroid individuals, though this shortens in hyperthyroid states 2. Standard therapeutic doses range from 5 to 75 mcg daily. A single dose of 25 mcg can raise serum T3 by 200 to 300 ng/dL above baseline within hours.

Why T3 Is Different from T4 in Overdose

Levothyroxine overdoses tend to follow a slower, more predictable course because T4 must be converted to T3. T3 ingestions bypass this rate-limiting step entirely. The result is a faster onset of toxicity, a narrower window for decontamination, and a more abrupt hemodynamic impact. That pharmacokinetic difference makes liothyronine overdose a clinical scenario requiring earlier and more aggressive monitoring than T4 overdose alone.

Recognizing Liothyronine Overdose: Symptoms and Timeline

The clinical picture of liothyronine excess mirrors thyrotoxicosis, but the timeline depends on whether the exposure is acute (single large ingestion) or chronic (repeated supratherapeutic dosing over weeks).

Acute Single Ingestion

Symptoms rarely appear immediately. A delay of 6 to 12 hours is typical, with full clinical effects sometimes not manifesting until 24 to 72 hours post-ingestion 3. Early signs include anxiety, restlessness, and mild tremor. As serum T3 rises, patients develop tachycardia, palpitations, diaphoresis, diarrhea, and fever. Severe cases produce wide-pulse-pressure hypertension, atrial fibrillation, psychosis, and seizures.

A 2010 review of thyroid hormone ingestions reported to US Poison Control Centers (N = 4,602 cases from 2000 to 2009) found that the vast majority of isolated acute ingestions resulted in minor or no clinical effects 4. Fatal outcomes from pure T3 overdose remain exceedingly rare in published case series.

Chronic Supratherapeutic Exposure

Patients taking liothyronine above prescribed doses for weeks or months present differently. Weight loss, heat intolerance, and menstrual irregularities develop gradually. The cardiovascular risks are more insidious: a Danish population-based cohort study (N = 586,460) demonstrated that even subclinical hyperthyroidism (endogenous or iatrogenic) raised atrial fibrillation risk by 30% and hip fracture risk by 28% over 7 years of follow-up 5. Chronic T3 excess also accelerates bone resorption, a concern especially for postmenopausal women on combination T4/T3 regimens.

Red Flags Requiring Emergency Evaluation

Any of the following after known or suspected liothyronine ingestion warrants immediate emergency department evaluation:

• Heart rate above 150 bpm or new irregular rhythm
• Core temperature above 39°C (102.2°F)
• Altered mental status, seizures, or psychotic features
• Chest pain or signs of cardiac ischemia
• Pediatric ingestion of any amount (children are more sensitive to thyroid hormone excess)

Emergency Treatment Protocol

Management follows the standard toxicology framework of stabilization, decontamination, targeted pharmacotherapy, and supportive care. No specific antidote for thyroid hormone overdose exists.

Airway, Breathing, Circulation

Secure IV access. Obtain a 12-lead ECG immediately. Place the patient on continuous cardiac monitoring. Draw baseline labs including free T3, free T4, TSH, comprehensive metabolic panel, and troponin if chest pain is present. TSH will be suppressed but is not useful for gauging acute toxicity severity because pituitary suppression lags behind the serum T3 spike.

GI Decontamination

Activated charcoal (1 g/kg, max 50 g in adults) is the preferred decontamination method when the patient presents within 1 to 2 hours of a known large ingestion and has a protected airway 3. Whole-bowel irrigation is generally not indicated for immediate-release liothyronine tablets, which dissolve rapidly. Gastric lavage is rarely performed for thyroid hormone ingestions and carries aspiration risk that typically outweighs benefit.

Cholestyramine (4 g orally every 6 to 8 hours) has been used in severe thyrotoxicosis to interrupt enterohepatic recirculation of thyroid hormones 6. While most evidence comes from endogenous hyperthyroidism, the mechanism applies to exogenous T3 excess and may be considered in large ingestions, particularly when presentation is delayed beyond the activated charcoal window.

Beta-Blocker Therapy

Beta-blockers are the cornerstone of symptomatic management. They do not reduce thyroid hormone levels but control the adrenergic consequences of T3 excess.

Propranolol is preferred for several reasons. It crosses the blood-brain barrier (addressing agitation and tremor), has a mild inhibitory effect on T4-to-T3 conversion (clinically relevant in mixed T4/T3 ingestions), and has decades of use in thyrotoxicosis management 7. Typical dosing is 1 to 3 mg IV administered slowly, repeated every 5 to 10 minutes as needed, transitioning to oral propranolol 20 to 40 mg every 6 hours once stable. The 2016 American Thyroid Association guidelines for thyrotoxicosis management recommend propranolol as the first-choice beta-blocker for thyrotoxicosis-associated symptoms 7.

Esmolol infusion (50 to 200 mcg/kg/min after a 500 mcg/kg loading dose) is an alternative when precise heart rate titration is needed or when the patient has relative contraindications to longer-acting agents.

Avoid beta-blockers in patients with decompensated heart failure or severe bronchospasm. Diltiazem is a second-line option for rate control in those patients.

Glucocorticoids in Severe Cases

High-dose dexamethasone (2 mg IV every 6 hours) or hydrocortisone (100 mg IV every 8 hours) may be considered in severe toxicity approaching thyroid storm. Glucocorticoids reduce peripheral T4-to-T3 conversion and provide adrenal support during the hypermetabolic state. The ATA guidelines recommend glucocorticoids as part of thyroid storm management when the Burch-Wartofsky score exceeds 45 7.

What Does NOT Work

Thionamides (methimazole, propylthiouracil) block new thyroid hormone synthesis. They have no role in exogenous T3 overdose because the excess hormone is already manufactured and ingested. Radioactive iodine is similarly irrelevant.

Monitoring and Disposition

Who Needs Admission

All symptomatic patients require admission with telemetry monitoring for at least 24 hours. Given T3's half-life of approximately 1 to 2 days, symptoms can persist or worsen for 48 to 72 hours after a single large ingestion. The American Association of Poison Control Centers recommends a minimum 24-hour observation period for any thyroid hormone ingestion producing symptoms 4.

Serial Lab Monitoring

Free T3 levels should be repeated every 6 to 12 hours until trending downward. Electrolytes and glucose require monitoring because thyroid hormone excess can provoke hyperglycemia and shifts in potassium. Troponin should be trended if tachycardia is sustained or the patient has known coronary artery disease.

Discharge Criteria

Patients may be considered for discharge when heart rate remains below 100 bpm off beta-blockers, free T3 is declining toward the reference range (80 to 200 ng/dL), the patient is tolerating oral intake, and no arrhythmias have been documented on telemetry for at least 12 hours.

Distinguishing T3 Overdose from Thyroid Storm

Thyroid storm is a life-threatening decompensation of endogenous thyrotoxicosis carrying a mortality rate of 10% to 30% even with treatment 8. The Burch-Wartofsky Point Scale (BWPS) was designed for endogenous thyrotoxicosis, but it can help gauge severity in exogenous T3 toxicity as well.

Key Differentiators

The overlap is substantial. Both produce tachycardia, fever, and altered mental status. Three features help distinguish them:

1. History. A bottle of missing liothyronine tablets or a known dose change points to exogenous cause.
2. Thyroglobulin and radioactive iodine uptake (RAIU). In exogenous overdose, thyroglobulin is low or undetectable because the thyroid gland is suppressed. RAIU is near zero. These tests are not available stat in most EDs but confirm the diagnosis retrospectively.
3. Response to thionamides. If methimazole produces no improvement over 24 to 48 hours, suspect exogenous ingestion.

When the Lines Blur

A patient already taking liothyronine for hypothyroidism who accidentally doubles doses may present with features of both iatrogenic and endogenous excess if they have residual thyroid function. In these cases, treat the clinical picture aggressively and sort out the etiology once the patient is stabilized.

Special Populations

Pediatric Ingestions

Children who swallow a parent's liothyronine tablets are a common call to Poison Control. A retrospective analysis of the National Poison Data System found that among pediatric thyroid hormone exposures (ages 0 to 5), fewer than 2% developed moderate or severe symptoms 4. Any pediatric ingestion warrants a call to Poison Control (1-800-222-1222) and a low threshold for ED evaluation because children have higher metabolic sensitivity to T3.

Older Adults and Cardiac Comorbidity

Adults over 65 and patients with known atrial fibrillation, coronary artery disease, or heart failure face disproportionate risk from T3 excess. Even modest supratherapeutic levels can precipitate ischemia or unstable arrhythmias. The ATA recommends a lower therapeutic target (TSH 1.0 to 3.0 mIU/L) in older patients specifically to avoid iatrogenic thyrotoxicosis 9.

Pregnancy

Supratherapeutic thyroid hormone in pregnancy can cause fetal tachycardia, growth restriction, and preterm labor. Thyroid hormones cross the placenta in limited quantities, but maternal thyrotoxicosis itself impairs uteroplacental perfusion. Propranolol is category C in pregnancy. Esmolol has been used safely in obstetric emergencies but requires fetal heart rate monitoring.

Preventing Accidental Liothyronine Overdose

Most liothyronine excess events reported to poison centers are accidental: a missed dose followed by a double-up, confusion between T3 and T4 tablets, or a prescribing/dispensing error involving microgram-to-milligram miscalculation 4.

Practical Prevention Measures

• Use a pill organizer. Liothyronine's small tablet size (5, 25, or 50 mcg) makes it easy to lose track of whether a dose was taken.
• Store T3 and T4 tablets separately and in clearly labeled containers. Confusion between levothyroxine 50 mcg and liothyronine 50 mcg is a 10-fold potency error in biologic effect.
• Pharmacists should include auxiliary labels flagging the narrow therapeutic index.
• Prescribers switching patients from combination T4/T3 therapy to T3 monotherapy (or vice versa) should provide written dose conversion instructions. The Bunevicius protocol used a T3-to-T4 ratio of roughly 1:3 to 1:4 by mcg, though individual variation is significant 1.

What to Do If You Miss a Dose

If you realize you missed a dose within a few hours, take it. If it is close to the next scheduled dose, skip the missed one entirely. Never double up. Liothyronine's relatively short half-life means a single missed dose may cause mild fatigue or brain fog the next day, but doubling carries real cardiac risk, especially in patients over 60 or those with heart disease.

Long-Term Consequences of Repeated T3 Excess

Sustained supratherapeutic T3 exposure over months has measurable end-organ effects beyond the acute cardiovascular risks.

Bone

A meta-analysis of 25 studies (N = 2,480) found that suppressive thyroid hormone therapy reduced bone mineral density at the lumbar spine by 1.6% per year in postmenopausal women, with the effect driven primarily by excess T3 activity at the osteoblast 10. The Endocrine Society recommends DEXA monitoring every 1 to 2 years for any patient on long-term T3-containing regimens with a suppressed TSH 11.

Cardiac Remodeling

Chronic T3 excess promotes left ventricular hypertrophy independent of blood pressure. A cross-sectional echocardiographic study in patients with subclinical hyperthyroidism (N = 247) showed increased left ventricular mass index and impaired diastolic relaxation compared to euthyroid controls 12.

Cognitive and Psychiatric Effects

While the Bunevicius 1999 trial showed cognitive benefits of adding T3 to T4 at physiologic replacement doses, supratherapeutic T3 levels cause anxiety, insomnia, and in severe cases, frank psychosis. The relationship between dose and cognitive effect follows an inverted-U curve: too little impairs, optimal improves, and too much destabilizes 1.

Patients on liothyronine who develop new-onset anxiety or insomnia should have free T3 checked before adding psychiatric medications. The dose reduction, not an anxiolytic, is the correct intervention.